Testing the Efficacy, Safety, and PK of 20E in Patients With Obesity Who Are Starting Treatment With the GLP-1 Agonist Semaglutide for Weight Loss.

Clinical trial NCT07411378 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07411378
Sponsor: Biophytis
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Muscle Wasting Obesity & Overweight Obesity

Start date: 2026-07-01
Primary completion: 2027-06-01
Enrollment: 164

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.